View More Recent Stories

Mar 28, 2022 07:00AM Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Patients with Moderate-To-Severe Pruritus
Mar 8, 2022 04:01PM Cara Therapeutics (CARA) Announces Oral KORSUVA Data Selected for Late-Breaking Presentation at AAD
Mar 8, 2022 04:01PM Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Data Selected for Late-Breaking Presentation at 2022 American Academy of Dermatology Annual Meeting
Mar 8, 2022 04:01PM Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Data Selected for Late-Breaking Presentation at 2022 American Academy of Dermatology Annual Meeting
Mar 1, 2022 04:01PM Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
Mar 1, 2022 04:01PM Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
Feb 28, 2022 01:00AM Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients
Feb 25, 2022 07:15AM Cara Therapeutics (CARA) announces Kapruvia receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients
Feb 25, 2022 07:15AM Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients
Feb 25, 2022 07:15AM Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients
Feb 22, 2022 04:01PM Cara Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
Feb 22, 2022 04:01PM Cara Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
Feb 18, 2022 07:00AM Cara Therapeutics to Host Virtual R&D Day on March 11, 2022
Feb 18, 2022 07:00AM Cara Therapeutics to Host Virtual R&D Day on March 11, 2022
Jan 10, 2022 08:01AM Cara Therapeutics (CARA) Reports Positive Phase 3 Results in Japan for Difelikefalin Injection
Jan 10, 2022 08:00AM Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase 3 Clinical Study in Japan for the Treatment of Pruritus in Hemodialysis Patients
Jan 10, 2022 08:00AM Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase 3 Clinical Study in Japan for the Treatment of Pruritus in Hemodialysis Patients
Jan 3, 2022 04:01PM Cara Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
Jan 3, 2022 04:01PM Cara Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
Dec 20, 2021 07:01AM Cara Therapeutics (CARA) Announces CMS Grants TDAPA to KORSUVA Injection
Dec 20, 2021 07:00AM Cara Therapeutics Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injection
Dec 20, 2021 07:00AM Cara Therapeutics Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injection
Dec 22, 2020 04:05PM CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors
Dec 16, 2020 07:27AM SAB Biotherapeutics Announces New Appointments to its Board of Directors
Oct 29, 2014 12:01PM Streetinsider.com's Hot Lunchtime Reads 10/29: (TWTR) (BBRY) (ORB) (TGT)
Mar 10, 2014 10:00AM Cara Therapeutics, Inc. [CARA] to Ring The NASDAQ Stock Market Opening Bell
View More Recent Stories